towse ispor incoming president's remarks
DESCRIPTION
For the full text of Professor Towse's remarks, visit OHE News on the OHE website.TRANSCRIPT
ISPOR 2014 - 2015 President Elect
Adrian Towse, MA, MPhilOffice of Health Economics
London, UK
Incoming Presidential Address
1. Continuing to globalise2. Responding to growing payer demand for
evidence of value 3. Continuing to raise HEOR scientific
standards 4. Supporting the next generation of
researchers.
Challenges facing ISPOR
• Globalisation of ISPOR has to be linked to an understanding of decision making in emerging country health systems
• There is growing desire in low and middle income countries to achieve universal health coverage (UHC) for their populations
• Using HTA to support priority setting as part of UHC will be important
• A key question in HTA will be the potential transferability of evidence (its ‘public good’ characteristics)
• But so will creating incentives in health care systems to achieve better outcomes, and measuring performance
In other words, diverse health systems have different challenges. ISPOR has to anticipate and respond to these needs
The first challenge: globalisation
• Outcomes research is ‘the scientific discipline that evaluates the effect of health care interventions on patient related if not patient specific, clinical, humanistic and economic outcomes’
• Health care intervention: ‘a program, policy, measure, or activitydesigned to have an impact on an illness or disease in an individual or a population’
• Health care technology (for HTA) consists of:– Drugs, biologics, devices, procedures– Support systems, organisational, delivery and managerial systems
(e.g. disease management programme, health care payment system)
Source: ISPOR Book of Terms
Break out of narrow perspectives
Beijing, China6-9 September 2014
Early Registration Deadline:
22 July 2014
ISPOR Meetings
Amsterdam,
The Netherlands8-12 November 2014
Abstract Submission Deadline:
24 June 2014
MEETINGSISPOR Meetings
VIH Co-editors-in–chief
Publications strength
Michael Drummond Dan Mullins
VIHRI Co-editors-in–chief
Publications strength
Bong-Min Yang Federico Augustovski Dan Greenberg
VIH Impact Factor projected to be up
30%
Upcoming Webinars
Performance-Based Risk-Sharing Arrangements (July)
Budget Impact Analysis II (September)
Assessing the Evidence - Modeling Studies (November)
Assessing the Evidence - Observational Studies (October)
Assessing the Evidence - Indirect Treatment Comparison Studies (December)
ISPOR Task Force Reportsin Development
Good Practices on:
Cost-Effectiveness Analysis Alongside Clinical TrialsMulti-Criteria Decision Analysis for Health Care DecisionCollecting and Analyzing Utility Data for Economic ModelsModeling Health State Utility Values - Mapping
2014-2016 Directors
President Elect
2014-2015 ISPOR Board of Directors
2013-2015 Directors
Past President Treasurer
2014-2015 ISPOR Board of Directors
Providing efficient and effective health care is a
global challenge
ISPOR is a global organisation that exists to help meet
this challenge
Diverse health systems have different challenges. ISPOR has to anticipate and respond to these needs: must break out
of narrow perspectives
Thank You!The full text of Professor Towse’s remarks is available on the OHE blog, OHE News.